GNLX (STOCKS)
Genelux Corporation Common Stock
$2.530000
-0.010000 (-0.39%)
Prev close: $2.540000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas D. Zindrick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $113.81M
- Employees
- 24
- P/E (TTM)
- -2.92
- P/B (TTM)
- 8.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $8.00K |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $33.22M |
| Nonoperating Income/Loss | $1.07M |
| Operating Expenses | $33.22M |
| Research and Development | $19.85M |
| Other Operating Expenses | $13.37M |
| Operating Income/Loss | -$33.21M |
| Income/Loss From Continuing Operations After Tax | -$32.15M |
| Income/Loss From Continuing Operations Before Tax | $8.00K |
| Net Income/Loss | -$32.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$32.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$32.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.86 |
| Diluted Earnings Per Share | -$0.86 |
| Basic Average Shares | 37,176,527 |
| Diluted Average Shares | 37,176,527 |
| Assets | $19.03M |
| Current Assets | $15.13M |
| Noncurrent Assets | $3.90M |
| Fixed Assets | $2.17M |
| Other Non-current Assets | $1.73M |
| Liabilities | $7.48M |
| Current Liabilities | $6.23M |
| Noncurrent Liabilities | $1.26M |
| Equity | $11.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.54M |
| Liabilities And Equity | $19.03M |
| Net Cash Flow From Operating Activities | -$25.27M |
| Net Cash Flow From Operating Activities, Continuing | -$25.27M |
| Net Cash Flow From Investing Activities | $12.14M |
| Net Cash Flow From Investing Activities, Continuing | $12.14M |
| Net Cash Flow From Financing Activities | $9.90M |
| Net Cash Flow From Financing Activities, Continuing | $9.90M |
| Net Cash Flow | -$3.23M |
| Net Cash Flow, Continuing | -$3.23M |
| Comprehensive Income/Loss | -$32.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$32.20M |
| Other Comprehensive Income/Loss | -$32.20M |